NEW YORK, May 18 - Nanogen is gearing up to launch its first clinical diagnostic products and to see its revenues from product sales increase substantially this year, Kieran Gallahue, the company's president said Friday.

We are accelerating the march to clinical diagnostics," Gallahue told GenomeWeb. "Right now we're selling to clinical researchers, then the next stage is to sell to clinical labs and then to various sized hospitals."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.